Denny Rogers, Managing Partner for Lander’s Chrysler/ Dodge/Jeep/Ram in Bossier City, made a $55,000 donation on Tuesday morning to the Pancreatic Cancer Action Network (“Pan Can”). The donation was made with monies raised from the second annual Renee’s Run event held in late November. The check presentation event was held at the dealership.
In an early November interview printed in the Bossier Press Tribune, Rogers told BPT Managing Editor Amanda Simmons that Renee’ Rogers will always be remembered for the passionate, selfless life she lived. Furthermore, her impact was widespread, touching many lives through community and church organizations, by honoring local student athletes and supporting numerous educational endeavors, Rogers went on to say.
Renee’ Rogers was also well known in the pageant circuit as the owner of Chelsea Couture in Shreveport, dressing many of the competitors in both the Miss Louisiana/Teen America and Miss Louisiana/Teen USA systems, and as the mother of Miss Louisiana 2003.
Renee’s main focus, though, was family and children. Tragically, Renee’ lost her life to pancreatic cancer on Nov. 24, 2013.
Rogers, said he doesn’t know if her loss will ever get easier. His mission now – to continue making a difference in Renee’s honor. Rogers has started his mission off in great fashion by raising a grand total of $95,000 from the 2014 and 2015 Renee’s Run events.
“We are putting a face to this disease,” Rogers said. “It knows no boundaries…male, female, race. There are 134 Americans diagnosed every day. Of those diagnosed within the last five years, 111 of them will lose their battle daily. We are focused on changing that.”
Of the major cancers, pancreatic cancer has the lowest survival rate. Pancreatic cancer is the only major cancer with a 5-year relative survival rate in the single digits, at just 7 percent.
The Pancreatic Cancer Action Network’s vision is to double the survival rate by the year 2020. Funds raised through events like Renee’s Run will help increase investments in research, fuel efforts to develop early detection tools and provide better treatment options for patients.